www.hackedexams.com/item/88065/t...
TEST BANK For Clinical Guidelines In Primary Care 4th Edition By Constance R Uphold And Mary Virginia Graham
#testbank #clinicalguidelines #primarycare #4thedition #hackedexams

What’s new in #PaediatricAnaesthesia?
🎙️ Listen to Eva Roofthooft and Arash Afshari discuss the 2025 ESAIC and ESPA Guidelines on neuromuscular block in anaesthetised children, covering indications, monitoring and safe reversal.
zurl.co/zZuQA

#PatientSafety #EJApodcast #ClinicalGuidelines

The 2026 ACC/AHA Multisociety #Dyslipidemia Guideline-at-a-Glance offers a visual summary of key updates in CV risk assessment, lipid treatment goals, & #ASCVD risk reduction.

A quick reference for clinicians: https://bit.ly/4rGIMHY

#JACC #ClinicalGuidelines #cvLipids #CardioSky

🆕 ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management & monitoring of individuals w/ dyslipidemias.

Read the full guideline in #JACC: https://bit.ly/4cLB0J0 #cvLipids #ClinicalGuidelines #CardioSky #MedSky

ACC/AHA & 9 other leading medical associations released an updated clinical guideline for managing #dyslipidemia. About 1 in 4 US adults has high LDL-C, raising risk of heart attack & stroke.

Get the details in #JACC: https://bit.ly/4cLB0J0

#ClinicalGuidelines #cvLipids #ASCVD #CardioSky

Welcome! You are invited to join a meeting: USGN Webinar: GRADE for Multiple Comparisons . After registering, you will receive a confirmation email about joining the meeting. Welcome! You are invited to join a meeting: USGN Webinar: GRADE for Multiple Comparisons . After registering, you will receive a confirmation email about joining the meeting.

Did you know that GRADE can be used when comparing multiple interventions against one another? Join us Friday, March 20 at 12pm EDT for a free #webinar on how to apply GRADE for multiple comparisons! Register at us02web.zoom.us/meeting/regi...

#ebm #evidencebasedmedicine #clinicalguidelines

The 2025 ESAIC and ESPA Guidelines on neuromuscular block in anaesthetised children are now available.
Access the full guideline: zurl.co/PnT1q

#ESAIC #ClinicalGuidelines #Anaesthesiology #PatientSafety #Paediatrics

EQUAL Score Aspergillosis - Apps on Google Play Tool for clinicians and measuring the quality of aspergillosis management

📱 Improve your clinical practice with the EQUAL Score Aspergillosis app! Quantify guideline adherence for pulmonary Aspergillosis treatment. Designed for hospital physicians.
Learn more: equal.uni-koeln.de/aspergillosi... #Aspergillosis #ECMM #ClinicalGuidelines #EQUALScore #MedicalApp

Today we launch the ESAIC App.
Clinical guidelines, education, congress updates and Society news — in one place.

📲 Download now:
iOS zurl.co/qhEyT
Android zurl.co/23GJ9

#ESAIC #Anaesthesia #IntensiveCare #ClinicalGuidelines

2026 ACC/AHA/Multisociety guideline on acute pulmonary embolism highlights practice-changing recommendations for the evaluation & management of acute PE in adults.

Explore the Guideline-at-a-Glance in #JACC to accelerate adoption in practice: https://bit.ly/4rwGoEd #ClinicalGuidelines #CardioSky

The 🆕 ACC/AHA Guideline for the Evaluation & Management of Acute Pulmonary Embolism (PE) in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, management & follow‑up of adults w/ acute PE.

Read more: https://bit.ly/4aE5gmi #ClinicalGuidelines

🆕 ACC/AHA/Multisociety Guideline for the Evaluation & Management of Acute PE in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, management & follow‑up of adults with acute PE. https://bit.ly/4aE5gmi

#JACC #CardioSky #ClinicalGuidelines

TEST BANK For Clinical Guidelines In Primary Care Fourth Edition By Amelie Hollier
#testbank #testbankforclinicalguidelines #4thedition #clinicalguidelines #Hollier #PrimaryCare #nursing #hackedexams

www.hackedexams.com/item/116233/...

Violet light significantly increases bruise detection across skin tones, researchers say In an NIJ-funded randomized longitudinal study presented by George Mason and Texas A&M researchers, alternate light at ~415 nm and 450 nm (with yellow/orange filters) substantially increased bruises detected versus white light and produced clinically meaningful visibility gains; authors urged standardized guidelines before routine clinical rollout.

Researchers have discovered that specific wavelengths of violet light can boost bruise detection rates by up to five times compared to regular white light, revolutionizing clinical and forensic practices.

Learn more here!

#US #VirginiaForensics #ClinicalGuidelines #CitizenPortal

This clinical practice guideline offers recommendations for the diagnosis, staging, and treatment of Rhabdomyosarcoma, grounded in the latest evidence and expert consensus.
doi.org/10.1016/j.xi...
#ClinicalGuidelines #rhabdomyosarcoma

Health First Colorado to pilot small DRG audits, says ambiguous cases will favor providers Health First Colorado staff said they will pilot a small DRG audit that uses clinical guidelines as a baseline but also reviews resource use; preliminary findings will remain preliminary under Senate Bill 314, and the department plans to publish the guidelines that vendors will apply.

Health First Colorado is launching a pilot DRG audit that could change the game for providers by favoring them in cases of ambiguous documentation!

Learn more here

#CO #ClinicalGuidelines #HealthcareReform #CitizenPortal

Medical experts at Berkeley County town hall warn of kratom risks, especially powerful synthetic derivatives Emergency physicians and prevention specialists described kratom’s pharmacology and clinical harms, saying lab‑made derivatives like 7‑hydroxy mitragynine can be far more potent and unpredictable than the plant’s native alkaloids and can require clinical treatment similar to opioid withdrawal.

Kratom may seem harmless, but experts warn its potent synthetic derivatives could pose serious health risks and complicate treatment for overdose victims.

Learn more here

#BerkeleyCounty #SC #ClinicalGuidelines #CommunityEducation #SubstanceAbuse #CitizenPortal #BerkeleyCountyPublicHealth

Antibiotics: Protein Synthesis Inhibitors – Mechanisms, Uses, and Clinical Nursing Considerations #Antibiotics #ProteinSynthesisInhibitors #Macrolides #Aminoglycosides #iprkashmishra #Tetracyclines #Lincosamides #NursingConsiderations #Pharmacology #Microbiology #ClinicalGuidelines #MedEd #DrugMechanisms

Antibiotics: Protein Synthesis Inhibitors – Mechanisms, Uses, and Clinical Nursing Considerations
#Antibiotics #ProteinSynthesisInhibitors #Macrolides #Aminoglycosides #iprkashmishra #Tetracyclines #Lincosamides #NursingConsiderations #Pharmacology #Microbiology #ClinicalGuidelines #MedEd

Starting the new year by highlighting the clinical impact of research published in TCRT! @tcrtcancer.bsky.social

View TCRT articles cited in clinical guidelines: journals.sagepub.com/page/tct/art...

Happy New Year! @journals.sagepub.com

#CancerResearch #ClinicalGuidelines #Oncology #OncoDaily

#ONCOnews #OncoAlert #OncEd #MultipleMyeloma #ASCO #ClinicalGuidelines #Hematology #Oncology

A Clinical Review of the 2025 Neuromyelitis Optica Spectrum Disorder Guidelines | NeurologyLive - Clinical Neurology News and Neurology Expert Insights Benjamin Greenberg, MD, MHS, a nationally recognized neuroimmunologist and contributor to the NMOSD diagnostic guidelines, spoke about the clinical impact of the recently published recommendations and...

🧠 New 2025 #NMOSD diagnostic guidelines are here!

Experts clarify AQP4+ vs antibody-negative disease, spotlight mimics like MOGAD, and aim to protect access to FDA-approved therapies 💊

Read more → www.neurologylive.com/view/clinica...
#Neurology #RareDisease #ClinicalGuidelines

New ESTRO-ISRS Clinical Guidelines - OncoDaily New ESTRO-ISRS Clinical Guidelines / cancer, clinical guidelines, ESTRO, ESTRO-ISRS, Headlines, ISRS, OncoDaily, Oncology, radiation oncology, radiotherapy

New ESTRO-ISRS Clinical Guidelines

@estroradiotherapy.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO #ISRS #ClinicalGuidelines

🆕 ACC/AHA guideline addresses management of #ACHD. The guideline provides updated recommendations for monitoring, counseling and treating ACHD and replaces previous guidance released in 2018.

Read the full guideline here ➡️ https://bit.ly/3Y4KM0d

#ClinicalGuidelines #JACC #CardioSky #MedSky

Evaluating the Accuracy of Medical Information Generated by ChatGPT and Gemini and Its Alignment With International Clinical Guidelines From the Surviving Sepsis Campaign: Comparative Study Background: Assessment of medical information provided by artificial intelligence (#AI) (AI) chatbots like ChatGPT and Google’s Gemini and comparison with international guidelines is a burgeoning area of research. These AI models are increasingly being considered for their potential to support clinical decision-making and patient education. However, their accuracy and reliability in delivering medical information that aligns with established guidelines remain under scrutiny. Objective: This study aims to assess the accuracy of medical information generated by ChatGPT and Gemini and its alignment with international guidelines for sepsis management. Methods: ChatGPT and Gemini were asked 18 questions about the Surviving Sepsis Campaign guidelines, and the responses were evaluated by 7 independent intensive care physicians. The responses generated were scored as follows: 3=correct, complete, and accurate; 2=correct but incomplete or inaccurate; and 1=incorrect. This scoring system was chosen to provide a clear and straightforward assessment of the accuracy and completeness of the responses. The Fleiss κ test was used to assess the agreement between evaluators, and the Mann-Whitney U test was used to test for the significance of differences between the correct responses generated by ChatGPT and Gemini. Results: ChatGPT provided 5 (28%) perfect responses, 12 (67%) nearly perfect responses, and 1 (5%) low-quality response, with substantial agreement among the evaluators (Fleiss κ=0.656). Gemini, on the other hand, provided 3 (17%) perfect responses, 14 (78%) nearly perfect responses, and 1 (5%) low-quality response, with moderate agreement among the evaluators (Fleiss κ=0.582). The Mann-Whitney U test revealed no statistically significant difference between the two platforms (P=.48). Conclusions: ChatGPT and Gemini both demonstrated potential for generating medical information. Despite their current limitations, both showed promise as complementary tools in patient education and clinical decision-making. The medical information generated by ChatGPT and Gemini still needs ongoing evaluation regarding its accuracy and alignment with international guidelines in different medical domains, particularly in the sepsis field.

JMIR Formative Res: Evaluating the Accuracy of Medical Information Generated by ChatGPT and Gemini and Its Alignment With International Clinical Guidelines From the Surviving Sepsis Campaign: Comparative Study #MedicalAI #HealthTech #ClinicalGuidelines #ChatGPT #Gemini

Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.
Alpert, Joseph S et al.
Paper
Details
#NSTEACS #Cardiology #ClinicalGuidelines

Kidney stones are common, but recurrence can often be prevented.
Our updated Australian & NZ guidelines bring the latest evidence on diagnosis, prevention, and management—helping clinicians improve outcomes.
Read more: www.cariguidelines.org/guidelines/k...
#KidneyStones #ClinicalGuidelines

Evaluation of the 2020 American Urological Association Microscopic Hematuria Guidelines in Clinical Practice: Retrospective Chart Review Analysis Background: Background: Hematuria is one of the most common urologic diseases seen within clinical practice with a prevalence range of 1.7-31.1%. In 2020, new American Urological Association (AUA) guidelines were revised which recommended that following initial evaluation, clinicians should categorize patients into three tiers (low risk, intermediate risk and high risk) based on various factors. Recent literature has shown the AUA guidelines to have high clinical utility when compared to other international guidelines such as the Hematuria Risk Index, Canadian Urological Association and Kaiser Permanente; however, this guideline remains unvalidated amongst the population of “well adults” within the United States. Objective: We utilized a retrospective study design to evaluate data abstracted from the electronic medical records of patients seen in the Emory Healthcare Executive Health Clinic from 9/29/2017 to 1/29/2021 to investigate the utility of risk stratification as a tool for clinical decision-making. Methods: According to AUA risk stratification system, patients were stratified into low- and intermediate/high-risk groups based on sex, age, smoking history, history of gross hematuria, and RBC/HPF. The frequencies and percentages of different causes of hematuria across the four risk strata were reported. Results: Of the instances of URBC >=3, 368(41.72%) underwent a repeat analysis within a 6-month time span, 184 (20.86%) within 12-month time span, and 330(37.41%) at > 12 months. Instances of a URBC3. 100% of participants in the LoR group resulted in post urinalysis of no urologic diagnosis versus 75.62% in the InR/HiR group Conclusions: We found a need for a greater focus on monitoring elevated URBC counts, in accordance with clinical guidelines for managing hematuria in low-risk patients. Future research should examine the impact of risk stratification on clinical decisions and access to care, especially in underserved populations. It should also assess how the new AUA guidelines affect physician referral patterns and explore real-world implementation challenges and facilitators.

JMIR Formative Res: Evaluation of the 2020 American Urological Association Microscopic Hematuria Guidelines in Clinical Practice: Retrospective Chart Review Analysis #Urology #Hematuria #AUA2020 #ClinicalGuidelines #Healthcare

GIN NA Webinar: Building Better Guidelines Together: Introducing the GIN Guidelines Collaboration Toolkit

🚀 Join GIN-North America for a FREE webinar on building clinical guidelines, and learn about the new GIN Guidelines Collaboration Toolkit from experts!

📅 Date: Thurs, Dec 11, 2025
⏰ Time: 12:00 PM - 1:00 PM EST
📍 Online
🎟️ Registration: connect.g-i-n.net/events/691c4...
#ClinicalGuidelines #GIN

REMINDER: There is still time to comment on the KDIGO Heart Failure in CKD Guideline Scope of Work, open for public review through December 1, 2025.

You can download the Scope of Work and submit feedback via the survey here:
kdigo.org/guidelines/h...

#HeartFailure #CKD #ClinicalGuidelines

Implementation of the German Clinical Practice Guideline for Multimorbidity Using a Digital Tool in Primary Care: Pilot Cluster Randomized Clinical Trial Background: Clinical practice guidelines (CPGs) summarize the best available evidence in a specific field. To improve patient-centered outcomes, guidelines have to be implemented, using, for example, information and communications technology. Although there are CPGs addressing multimorbidity, there is still a lack of studies investigating their implementation. Objective: This study aimed to evaluate whether the implementation of a CPG for multimorbidity using a digital tool is feasible and explore possible effects of this intervention. Methods: A pilot cluster randomized clinical trial based on telephone interviews was conducted from October 25, 2023, to September 8, 2024. Patients enrolled in any disease management program who were aged ≥65 years and had at least 2 additional chronic conditions were randomly selected from 20 general practitioner (GP) practices and contacted for informed consent. Each practice was randomized after baseline interviews of all participating patients in the practice were finished. The use of a web application facilitating collection and documentation of treatment-relevant data in accordance with the German CPG for multimorbidity was compared with treatment as usual. The primary outcome was time spent in hospital. As a secondary outcome, the number of patients with at least one hospital admission was calculated. Further secondary outcomes included outpatient health care use, quality of life, patient satisfaction, and quality of care. Feasibility assessment included examination of sample size, participation rate, and compliance with the study protocol. Outcome measures were analyzed using linear, logistic, and negative binomial regressions with random intercepts for practices. Results: Of 384 patients who were contacted, 123 (32%) agreed to participate, and 120 (31.3%, including 54/120, 45% in the intervention group and 66/120, 55% in the control group) completed baseline and follow-up assessments. Mean age was 75.4 (SD 6.6) years, and 51.7% (62/120) were women. The compliance rate, or the proportion of patients who were treated per protocol, was 89% (48/54). In our data, the incidence rate of hospital days was comparable in both groups (incidence rate ratio [IRR] 0.94, 95% CI 0.09-9.42; P=.96), but the odds of hospital admission were almost reduced by half in the intervention group (odds ratio 0.51, 95% CI 0.17-1.54; P=.23). Our data also suggest a higher incidence rate of GP contacts (IRR 1.13, 95% CI 0.83-1.53; P=.43) and lower incidence rate of contacts with outpatient specialists (IRR 0.79, 95% CI 0.54-1.15; P=.24) in the intervention group compared to usual care. Moreover, patients and GPs reported a better quality of care (mean difference 0.51, 95% CI −0.12 to 1.14; P=.12 and mean difference 1.19, 95% CI 0.13-2.25; P=.03, respectively) in the intervention group. Conclusions: Implementation of the CPG using a digital tool was feasible. Our data suggest that the probability of hospital admissions and contacts with outpatient specialists might be reduced and quality of care might be improved. Trial Registration: ClinicalTrials.gov NCT06061172; https://clinicaltrials.gov/study/NCT06061172

New in JMIR Aging: Implementation of the German Clinical Practice Guideline for Multimorbidity Using a Digital Tool in Primary Care: Pilot Cluster Randomized Clinical Trial #Multimorbidity #DigitalHealth #ClinicalGuidelines #PatientCare #PrimaryCare